BioVentrix Acquires MateraCor, Inc.

Viant Acquires Meraqi Medical

September 11, 2019

Medical Devices

Viant, a global medical device design and manufacturing services provider, has acquired Meraqi Medical, a Silicon Valley-based design, development and manufacturing firm focused on bioelectronics and minimally invasive surgical devices. The deal expands Viant's front-end design and development capabilities, adds a West Coast D&D hub, and deepens its portfolio of medtech solutions as an add-on to its PE-backed platform.

Warburg Pincus Invests $100M in Matera

July 17, 2024

Cloud & SaaS

Warburg Pincus has made a $100 million growth investment in Matera to fund the Brazilian banking software provider’s expansion into North America and to accelerate product development. Matera, a provider of core banking, instant payments and QR code payment solutions used by more than 250 financial institutions, reported $77 million of revenue in 2023 and has a team of over 1,000 professionals.

Valo Health Acquires TARA Biosystems

April 5, 2022

Biotechnology

Valo Health has acquired TARA Biosystems, a New York City–based company specializing in human 3D tissue engineering and cardiac disease modeling, to create an integrated cardiovascular drug discovery and development platform. The deal combines TARA's in vitro cardiac models with Valo's Opal computational platform to expand Valo's capabilities in cardiovascular drug discovery and accelerate development of new therapies.

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

Medix Biochemica Group Acquires Bioresource Technology (BRT)

June 21, 2022

Biotechnology

Medix Biochemica has acquired a 100% stake in US-based Bioresource Technology (BRT) to expand its base matrix capabilities and strengthen its presence in the United States. BRT will be integrated into Medix Biochemica’s IVD Biomaterials Business Unit (St. Louis) while operations continue in Weston, Florida, and BRT leadership will serve as strategic advisors.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.